Lombard Investments, Inc.
US Elections Calendar ~ Pervez Musharraf ~ Iftikhar Muhammad Chaudhry ~ Other International News
Home / International News / Press Releases / May 05, 2008
Lombard Makes Investment in The Medical City, a Leading Philippine Hospital and Healthcare Provider

Top News

Karnataka High Court orders Ramoji Rao to appear in Ballari Court

At least 32 persons including six security men injured in grenade attack in J-K

Nepal may choose Indian-origin president today

TomKats daughter Suri is too old to drink from bottle

Wipro posts Rs 908 Crore net

China prepares to greet Olymipics visitors with a warm Hello

Now, a painless microneedle that mimics a mosquitos bite

Rise in research journals online causing researchers to cite fewer, newer papers

Lombard Makes Investment in The Medical City, a Leading Philippine Hospital and Healthcare Provider

SAN FRANCISCO, May 5 /PRNewswire/ -- Lombard Investments, Inc. is pleased to announce the acquisition of 18% of Professional Services, Inc. ("PSI" or the "Company"), owner and operator of The Medical City, a leading, private tertiary-care hospital in the Philippines. Its facilities include a 500 bed hospital complex (soon to be expanded to 750 beds) and 280 medical clinics.

PSI is managed by a group of leading physicians and other professionals led by Alfredo R.A. Bengzon, a former Secretary of Health and Dean of the prestigious Ateneo School of Medicine and Public Health in the Philippines. The management team's recent achievements include securing as of February 2007 the Joint Commission International Accreditation ("JCIA"), the most widely recognized international healthcare certificate. The Medical City is one of only two hospitals in the Philippines to receive such a distinction.

Mr. Pote Videt, Managing Director of Lombard Investments, Inc., said, "Lombard is pleased to become a long-term investor and board member of PSI. The Medical City is well-positioned to benefit from the strong domestic demand for private healthcare as well as a growing international medical tourism industry. Through Lombard's representation on the board of directors of the Company, we look forward to many years of fruitful co-operation."

About Lombard Investments:

Lombard is a leading international private equity investment manager with offices in Bangkok, Hong Kong and San Francisco. Formed in 1985, Lombard has made more than 75 controlling and significant minority investments in Asia and North America. The firm's investors include some of the world's largest and most respected financial institutions, major pension funds and corporations, as well as family investment offices in Asia, North America and Europe. Lombard made its investment in PSI through Lombard Asia III, the firm's South East Asia and Greater China private equity fund. (http://www.lombardinvestments.com)

     More information is available by visiting
     http://www.lombardinvestments.com or by contacting:

     Mr. Thomas Smith, Managing Director    Mr. Pote Videt, Managing Director
     Email: tsmith@lombardinvestments       Email: pote@lombardinvestments.com

SOURCE Lombard Investments, Inc.

International News / Press Release source: PR Newswire
Copyright PR Newswire. All Rights Reserved.

International Business News / Press Releases

/C O R R E C T I O N -- China Sky One Medical, Inc./
PR Newswire

Cohen & Steers Funds Quarterly Data Now Available
PR Newswire

Galderma Announces Approval for Differin(R) Gel 0.1% in Japan
PR Newswire

Back-to-Back Top 10 Finishes for Indy Racing League Rookie Mario Moraes
PR Newswire

MutualFirst Announces Increased Second Quarter 2008 Earnings
PR Newswire

International Health News / Press Releases

/C O R R E C T I O N -- China Sky One Medical, Inc./
PR Newswire

Galderma Announces Approval for Differin(R) Gel 0.1% in Japan
PR Newswire

Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU
PR Newswire

Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc.
PR Newswire

Pharmasset Announces $25.9 Million Registered Direct Offering of Common Stock
PR Newswire

International Medical News / Press Releases

/C O R R E C T I O N -- China Sky One Medical, Inc./
PR Newswire

Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU
PR Newswire

Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc.
PR Newswire

Simcere Pharmaceutical Group to Announce Second Quarter 2008 Earnings on Tuesday, August 5, 2008
PR Newswire

Genesis Pharmaceuticals Announces SFDA Approval for Radix Isatidis Dispersible Tablets
PR Newswire